Malignant melanocytic lesions in clinically suspected pterygium

Read full text
Authors: Rozina Ida Hajdú, Paola Kammrath Betancor, Othmane Touirssa, Claudia Auw-Haedrich, Thomas Reinhard, Simone Nuessle
Cited by: 1
References: 10

Abstract

AIMS: To determine the prevalence and clinicopathological features of malignant melanocytic lesions in specimens clinically diagnosed as pterygia. METHODS: This retrospective study analysed all conjunctival specimens submitted with the clinical diagnosis 'pterygium' to the ophthalmic pathology laboratory of the Eye Center, University of Freiburg, Germany, between August 1999 and August 2024. Specimens that unexpectedly revealed a histopathological diagnosis of malignant melanocytic lesions were further reviewed for their clinical and pathological characteristics. RESULTS: Among 2298 clinically presumed pterygia, seven specimens (0.30%) harboured a malignant melanocytic lesion: four (0.17%) were invasive conjunctival melanomas and three (0.13%) were high-grade conjunctival melanocytic intraepithelial lesions (C-MIL). Three of four melanomas were amelanotic or hypomelanotic (75%) or exhibited atypical temporal localisation (75%). CONCLUSION: Malignant melanocytic lesions, though rare, may arise within or mimic pterygia. Their often amelanotic presentation can complicate clinical recognition. Routine histopathological evaluation of all excised pterygia is therefore essential to detect unexpected malignancies as conjunctival melanoma C-MIL.

Fields of Study & Subjects

Ocular Oncology and Treatments Corneal Surgery and Treatments Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
British Journal of Ophthalmology
Publisher
BMJ
Volume
110
Issue
9
Pages
997–1001
Publication date
26 February 2026
Language
EN